Try our Advanced Search for more refined results
Private Equity
Private Equity Law360 provides breaking news and analysis on private equity deals and the attorneys involved. Coverage includes high-impact deals, related litigation and enforcement actions, and policy developments that affect private equity firms.
Sign up for a 7-day FREE trial today!
Latest News in Private Equity
-
February 04, 2026
Ropes Leads Hair-Loss Firm Veradermics' Upsized $256M IPO
Hair loss drug developer Veradermics Inc. began trading Wednesday after raising $256 million in an upsized initial public offering, with Ropes & Gray LLP representing the company and Cooley LLP representing the underwriters.
-
February 04, 2026
SEC Cases May Rise After 'Unprecedented' 2025, Attys Say
Following an "unprecedented" year in which the U.S. Securities and Exchange Commission dismissed the bulk of its crypto docket and filed few new lawsuits, former SEC staff members said Wednesday that there are signs that enforcement actions could begin to ramp up this year.
-
February 04, 2026
Stem-Cell Drug Developer PrimeGen Inks $1.5B SPAC Merger
Regenerative medicine developer PrimeGen US said Wednesday it has agreed to go public through a merger with blank check company DT Cloud Star Acquisition Corp., in a deal that values the company at about $1.5 billion.
-
February 04, 2026
Seidler Family Resolves Most Of Padres Ownership Dispute
A dispute over control of the San Diego Padres appears to be over, as the widow of the team's late owner has dropped several claims against his brothers just months after the Major League Baseball team announced it was putting itself up for sale.
-
February 04, 2026
Fintech Broker Clear Street Targets $1B IPO
Cloud-based financial services provider Clear Street Group Inc. said Wednesday it anticipates a $1 billion initial public offering, represented by Davis Polk & Wardwell LLP and underwriters counsel Cooley LLP.
Areas of Coverage
- TRANSACTIONS
- Private equity deals valued at $50MM or more
- Venture capital investments of $25MM or more
- Mergers and acquisitions
- Capital investments, including mezzanine and growth capital deals
- Joint ventures involving private equity firms
- Hostile takeovers and leveraged buyouts
- Distressed investment deals
- AGENCIES
- U.S. Commodity Futures Trading Commission
- Federal Trade Commission
- Financial Industry Regulatory Authority
- Public Company Accounting Oversight Board
- U.S. Department of Justice
- U.S. Department of the Treasury
- U.S. Securities and Exchange Commission
- International competition and securities regulators
- POLICY & REGULATION
- Dodd-Frank Act
- Delaware corporate law
- Antitrust and consumer protection controls
- Private equity industry lobbying
- International banking legislation and regulation
- ENFORCEMENT
- Merger reviews
- Second requests
- Challenges and divestitures
- Litigation
- Antitrust suits
- Shareholder disputes
- Corporate governance fights
- Poison pill challenges
- Hostile takeover disputes
- Privacy and consumer protection suits
- Bankruptcy proceedings involving private equity stakeholders
- PROFILES
- Personnel moves
- Profiles of private equity practices
Readership
- Private equity lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the private equity industry
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals